Related Experiment Video
Updated: May 20, 2025

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Management of Cardiovascular Health Issues in Turner Syndrome: Expert Insights and Expanded Recommendations From the
Katya de Groote1, Sheetal R Patel2, Kristian Havmand Mortensen3
1Department of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
Insights
Turner syndrome (TS) often involves congenital heart disease (CHD), increasing mortality risk. Lifelong cardiovascular surveillance is crucial for managing these complex heart conditions in TS patients.
Area of Science:
- Cardiology
- Genetics
- Pediatrics
Background:
- Turner syndrome (TS) is frequently associated with congenital heart disease (CHD).
- Common CHD in TS includes bicuspid aortic valve and coarctation of the aorta.
- Cardiovascular complications are the leading cause of death in TS, highlighting the need for vigilance.
Purpose of the Study:
- To emphasize the significant burden of congenital heart and vascular lesions in TS.
- To highlight the importance of lifelong cardiovascular surveillance for individuals with TS.
- To discuss the rationale for clinical management of CHD in TS, considering TS-specific features.
Main Methods:
- Expert panel statement.
- Review of current clinical practice guidelines for TS.
- Focus on rationale for clinical management and follow-up care.
Main Results:
- Individuals with TS have a threefold increased standardized mortality rate compared to the general population.
- Cardiovascular complications, including aortic dissection, are the primary cause of death.
- TS presents unique CHD features that influence clinical decision-making.
Conclusions:
- The 2024 Clinical Practice Guidelines for TS underscore the necessity of addressing CHD.
- Lifelong cardiovascular surveillance is essential for managing TS-related heart conditions.
- Understanding TS-specific CHD features is critical for effective therapeutic options and follow-up.
Abstract:
Turner syndrome (TS) is frequently complicated by congenital heart disease (CHD). While left-sided lesions such as bicuspid aortic valve (BAV) and coarctation of the aorta are the most common structural heart lesions in TS, other anomalies, such as aortic arch malformations, hypoplastic left heart syndrome (HLHS), persistent left superior vena cava (LSVC), and partial anomalous pulmonary venous return (PAPVR), are also relatively frequent. Standardized mortality is increased threefold in individuals with TS compared to the general population, with cardiovascular complications, including aortic dissection, being the leading cause of death. The publication of the 2024 Clinical Practice Guidelines for TS marks an important opportunity to remind clinicians about the burden of congenital heart and vascular lesions in TS and the need for lifelong cardiovascular surveillance. In this expert panel statement, we will focus on the rationale for clinical management of CHD in TS, emphasizing TS-specific features of CHD that influence clinical decision making about therapeutic options and follow-up care.
More Related Videos
09:39Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
Published on: December 4, 2021
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Hormonal Regulation
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...